You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 4, April 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Sciences
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (36)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Endophthalmitis
 •Prostheses/ Implants
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Endophthalmitis After Keratoprosthesis

Incidence, Bacterial Causes, and Risk Factors

Mahnaz Nouri, MD; Hisao Terada, MD; Eduardo C. Alfonso, MD; C. Stephen Foster, MD; Marlene L. Durand, MD; Claes H. Dohlman, MD, PhD

Arch Ophthalmol. 2001;119:484-489.

Objectives  To determine the rate of endophthalmitis in a group of patients with keratoprostheses and to analyze possible risk factors.

Methods  A total of 108 patient eyes, operated on between 1990 and 2000 with double-plated keratoprostheses, were analyzed with regard to the surface flora, the incidence and cause of bacterial endophthalmitis or sterile vitreitis, the keratoprosthesis design, prophylactic antibiotics, concomitant immunosuppression, and preoperative diagnosis.

Results  Surveillance cultures were obtained from 30 uninfected eyes. The flora was similar to that reported in the normal population and did not vary significantly with time. Thirteen cases of bacterial endophthalmitis occurred 2 to 46 months postoperatively in the patient population that had been followed up for 2 months to 17 years (average, 3 years 4 months). The incidence was 39% in 13 patients with Stevens-Johnson syndrome, 19% in 27 patients with ocular cicatricial pemphigoid, and 7% in 28 patients with ocular burns. Only 1 of the other 40 cases (consisting mostly of repeated graft failures in noncicatrizing conditions) developed endophthalmitis; this patient had a filtering bleb. All endophthalmitis pathogens were gram positive: Streptococcus pneumoniae, 23%; other streptococci, 39%; Staphylococcus aureus, 23%; and Staphylococcus epidermidis, 15%.

Conclusions  The most important risk factor for endophthalmitis after these keratoprostheses was found to be preoperative diagnosis. The rate of infection was very high in Stevens-Johnson syndrome and ocular cicatricial pemphigoid, moderate in chemical burns, and low in noncicatrizing corneal disease.


From the Departments of Ophthalmology, Massachusetts Eye and Ear Infirmary, and Harvard Medical School, Boston (Drs Nouri, Terada, Foster, Durand, and Dohlman); and Bascom Palmer Eye Institute and University of Miami School of Medicine, Miami, Fla (Dr Alfonso). The authors have no proprietary interest in any device described in this article.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Archives of Ophthalmology Reader's Choice: Continuing Medical Education
Arch Ophthalmol. 2001;119(4):631.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Modified Osteo-odonto-keratoprosthesis for Treatment of Corneal Blindness: Long-term Anatomical and Functional Outcomes in 181 Cases
Falcinelli et al.
Arch Ophthalmol 2005;123:1319-1329.
ABSTRACT | FULL TEXT  

Biological Response to a SupraDescemetic Synthetic Cornea in Rabbits
Stoiber et al.
Arch Ophthalmol 2004;122:1850-1855.
ABSTRACT | FULL TEXT  

Five year follow up of biocolonisable microporous fluorocarbon haptic (BIOKOP) keratoprosthesis implantation in patients with high risk of corneal graft failure
Alio et al.
Br J Ophthalmol 2004;88:1585-1589.
ABSTRACT | FULL TEXT  

Seoul-Type Keratoprosthesis: Preliminary Results of the First 7 Human Cases
Kim et al.
Arch Ophthalmol 2002;120:761-766.
ABSTRACT | FULL TEXT  

Management of Vitreoretinal Complications in Eyes With Permanent Keratoprosthesis
Ray et al.
Arch Ophthalmol 2002;120:559-566.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.